Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 293

1.

Characterizing responsive and refractory orthotopic mouse models of hepatocellular carcinoma in cancer immunotherapy.

Hage C, Hoves S, Ashoff M, Schandl V, Hört S, Rieder N, Heichinger C, Berrera M, Ries CH, Kiessling F, Pöschinger T.

PLoS One. 2019 Jul 10;14(7):e0219517. doi: 10.1371/journal.pone.0219517. eCollection 2019.

PMID:
31291357
Free Article
2.

Perspective review of optical imaging in welfare assessment in animal-based research.

Pereira C, Kunczik J, Bleich A, Haeger C, Kiessling F, Thum T, Tolba R, Lindauer U, Treue S, Czaplik M.

J Biomed Opt. 2019 Jul;24(7):1-11. doi: 10.1117/1.JBO.24.7.070601.

PMID:
31286726
3.

Photoacoustic detection of superoxide using oxoporphyrinogen and porphyrin.

Merkes JM, Rueping M, Kiessling F, Banala S.

ACS Sens. 2019 Jul 2. doi: 10.1021/acssensors.9b00224. [Epub ahead of print]

PMID:
31262172
4.

MR and PET-CT monitoring of tissue-engineered vascular grafts in the ovine carotid artery.

Wolf F, Paefgen V, Winz O, Mertens M, Koch S, Gross-Weege N, Morgenroth A, Rix A, Schnoering H, Chalabi K, Jockenhoevel S, Lammers T, Mottaghy F, Kiessling F, Mela P.

Biomaterials. 2019 Sep;216:119228. doi: 10.1016/j.biomaterials.2019.119228. Epub 2019 May 27.

PMID:
31195299
5.

The reduction of astrocytes and brain volume loss in anorexia nervosa-the impact of starvation and refeeding in a rodent model.

Frintrop L, Trinh S, Liesbrock J, Leunissen C, Kempermann J, Etdöger S, Kas MJ, Tolba R, Heussen N, Neulen J, Konrad K, Päfgen V, Kiessling F, Herpertz-Dahlmann B, Beyer C, Seitz J.

Transl Psychiatry. 2019 Jun 4;9(1):159. doi: 10.1038/s41398-019-0493-7.

6.

Ultrasound Microbubbles for Diagnosis and Treatment of Cardiovascular Diseases.

Rix A, Curaj A, Liehn E, Kiessling F.

Semin Thromb Hemost. 2019 May 16. doi: 10.1055/s-0039-1688492. [Epub ahead of print]

PMID:
31096311
7.

Bone resorption and body reorganization during maturation induce maternal transfer of toxic metals in anguillid eels.

Freese M, Rizzo LY, Pohlmann JD, Marohn L, Witten PE, Gremse F, Rütten S, Güvener N, Michael S, Wysujack K, Lammers T, Kiessling F, Hollert H, Hanel R, Brinkmann M.

Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11339-11344. doi: 10.1073/pnas.1817738116. Epub 2019 May 13.

8.

Sorafenib Induces Pyroptosis in Macrophages and Triggers Natural Killer Cell-Mediated Cytotoxicity Against Hepatocellular Carcinoma.

Hage C, Hoves S, Strauss L, Bissinger S, Prinz Y, Pöschinger T, Kiessling F, Ries CH.

Hepatology. 2019 Apr 19. doi: 10.1002/hep.30666. [Epub ahead of print]

PMID:
31002440
9.

Elastin imaging enables noninvasive staging and treatment monitoring of kidney fibrosis.

Sun Q, Baues M, Klinkhammer BM, Ehling J, Djudjaj S, Drude NI, Daniel C, Amann K, Kramann R, Kim H, Saez-Rodriguez J, Weiskirchen R, Onthank DC, Botnar RM, Kiessling F, Floege J, Lammers T, Boor P.

Sci Transl Med. 2019 Apr 3;11(486). pii: eaat4865. doi: 10.1126/scitranslmed.aat4865.

PMID:
30944168
10.

Liver fibrosis affects the targeting properties of drug delivery systems to macrophage subsets in vivo.

Ergen C, Niemietz PM, Heymann F, Baues M, Gremse F, Pola R, van Bloois L, Storm G, Kiessling F, Trautwein C, Luedde T, Lammers T, Tacke F.

Biomaterials. 2019 Jun;206:49-60. doi: 10.1016/j.biomaterials.2019.03.025. Epub 2019 Mar 22.

PMID:
30925288
11.

Data Curation for Preclinical and Clinical Multimodal Imaging Studies.

Yamoah GG, Cao L, Wu CW, Beekman FJ, Vandeghinste B, Mannheim JG, Rosenhain S, Leonardic K, Kiessling F, Gremse F.

Mol Imaging Biol. 2019 Mar 13. doi: 10.1007/s11307-019-01339-0. [Epub ahead of print]

PMID:
30868426
12.

Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics.

Bartmann L, Schumacher D, von Stillfried S, Sternkopf M, Alampour-Rajabi S, van Zandvoort MAMJ, Kiessling F, Wu Z.

Front Pharmacol. 2019 Feb 6;10:79. doi: 10.3389/fphar.2019.00079. eCollection 2019.

13.

The CCR2+ Macrophage Subset Promotes Pathogenic Angiogenesis for Tumor Vascularization in Fibrotic Livers.

Bartneck M, Schrammen PL, Möckel D, Govaere O, Liepelt A, Krenkel O, Ergen C, McCain MV, Eulberg D, Luedde T, Trautwein C, Kiessling F, Reeves H, Lammers T, Tacke F.

Cell Mol Gastroenterol Hepatol. 2019;7(2):371-390. doi: 10.1016/j.jcmgh.2018.10.007. Epub 2018 Oct 18.

14.

PET performance evaluation of the small-animal Hyperion IID PET/MRI insert based on the NEMA NU-4 standard.

Hallen P, Schug D, Weissler B, Gebhardt P, Salomon A, Kiessling F, Schulz V.

Biomed Phys Eng Express. 2018 Nov;4(6):065027. doi: 10.1088/2057-1976/aae6c2. Epub 2018 Oct 24.

15.

Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications.

Dadfar SM, Roemhild K, Drude NI, von Stillfried S, Knüchel R, Kiessling F, Lammers T.

Adv Drug Deliv Rev. 2019 Jan 1;138:302-325. doi: 10.1016/j.addr.2019.01.005. Epub 2019 Jan 11. Review.

PMID:
30639256
16.

Molecular Imaging Unravels Cerebral Malaria.

Kiessling F.

Radiology. 2019 Feb;290(2):368-369. doi: 10.1148/radiol.2018182461. Epub 2018 Dec 4. No abstract available.

PMID:
30615551
17.

A preclinical micro-computed tomography database including 3D whole body organ segmentations.

Rosenhain S, Magnuska ZA, Yamoah GG, Rawashdeh WA, Kiessling F, Gremse F.

Sci Data. 2018 Dec 18;5:180294. doi: 10.1038/sdata.2018.294.

18.

A computational and experimental study to develop E-selectin targeted peptides for molecular imaging applications.

Fernandes AC, Liu M, Sorbo T, Appold LC, Ilbert M, Ferracci G, Kiessling F, F Branco RJ, Lammers T, Iranzo O.

Future Med Chem. 2018 Dec 6. doi: 10.4155/fmc-2018-0244. [Epub ahead of print]

PMID:
30520324
19.

Nanomedicine and macroscale materials in immuno-oncology.

Sun Q, Barz M, De Geest BG, Diken M, Hennink WE, Kiessling F, Lammers T, Shi Y.

Chem Soc Rev. 2019 Jan 2;48(1):351-381. doi: 10.1039/c8cs00473k. Review.

PMID:
30465669
20.

PLGA-Based Nanoparticles in Cancer Treatment.

Rezvantalab S, Drude NI, Moraveji MK, Güvener N, Koons EK, Shi Y, Lammers T, Kiessling F.

Front Pharmacol. 2018 Nov 2;9:1260. doi: 10.3389/fphar.2018.01260. eCollection 2018. Review.

21.

Sonopermeation to improve drug delivery to tumors: from fundamental understanding to clinical translation.

Snipstad S, Sulheim E, de Lange Davies C, Moonen C, Storm G, Kiessling F, Schmid R, Lammers T.

Expert Opin Drug Deliv. 2018 Dec;15(12):1249-1261. doi: 10.1080/17425247.2018.1547279. Epub 2018 Nov 19. Review.

PMID:
30415585
22.

Clinical Pilot Application of Super-Resolution US Imaging in Breast Cancer.

Dencks S, Piepenbrock M, Opacic T, Krauspe B, Stickeler E, Kiessling F, Schmitz G.

IEEE Trans Ultrason Ferroelectr Freq Control. 2019 Mar;66(3):517-526. doi: 10.1109/TUFFC.2018.2872067. Epub 2018 Sep 24.

PMID:
30273150
23.

Current and Emerging Preclinical Approaches for Imaging-Based Characterization of Atherosclerosis.

Vigne J, Thackeray J, Essers J, Makowski M, Varasteh Z, Curaj A, Karlas A, Canet-Soulas E, Mulder W, Kiessling F, Schäfers M, Botnar R, Wildgruber M, Hyafil F; Cardiovascular study group of the European Society of Molecular Imaging.

Mol Imaging Biol. 2018 Dec;20(6):869-887. doi: 10.1007/s11307-018-1264-1. Review.

PMID:
30250990
24.

Molecular ultrasound imaging of JAM-A depicts early arterial inflammation.

Kiessling F.

Aging (Albany NY). 2018 Sep 14;10(9):2222-2223. doi: 10.18632/aging.101555. No abstract available.

25.

Labeling of Collagen Type I Templates with a Naturally Derived Contrast Agent for Noninvasive MR Imaging in Soft Tissue Engineering.

Janke HP, Güvener N, Dou W, Tiemessen DM, YantiSetiasti A, Cremers JGO, Borm PJA, Feitz WFJ, Heerschap A, Kiessling F, Oosterwijk E.

Adv Healthc Mater. 2018 Sep;7(18):e1800605. doi: 10.1002/adhm.201800605. Epub 2018 Jul 29.

PMID:
30058274
26.

Radiomic analysis of contrast-enhanced ultrasound data.

Theek B, Opacic T, Magnuska Z, Lammers T, Kiessling F.

Sci Rep. 2018 Jul 27;8(1):11359. doi: 10.1038/s41598-018-29653-7.

27.

US Molecular Imaging Sensitively Captures Acute Ileitis Therapy Response.

Kiessling F.

Radiology. 2018 Oct;289(1):101-102. doi: 10.1148/radiol.2018181211. Epub 2018 Jul 24. No abstract available.

PMID:
30040043
28.

Tumor targeting via EPR: Strategies to enhance patient responses.

Golombek SK, May JN, Theek B, Appold L, Drude N, Kiessling F, Lammers T.

Adv Drug Deliv Rev. 2018 May;130:17-38. doi: 10.1016/j.addr.2018.07.007. Epub 2018 Jul 19. Review.

29.

Engineering biofunctional in vitro vessel models using a multilayer bioprinting technique.

Schöneberg J, De Lorenzi F, Theek B, Blaeser A, Rommel D, Kuehne AJC, Kießling F, Fischer H.

Sci Rep. 2018 Jul 11;8(1):10430. doi: 10.1038/s41598-018-28715-0.

30.

Targeting and Modulation of Liver Myeloid Immune Cells by Hard-Shell Microbubbles.

Warzecha KT, Bartneck M, Möckel D, Appold L, Ergen C, Al Rawashdeh W, Gremse F, Niemietz PM, Jahnen-Dechent W, Trautwein C, Kiessling F, Lammers T, Tacke F.

Adv Biosyst. 2018 May;2(5). pii: 1800002. doi: 10.1002/adbi.201800002.

31.

Development of a Polymer-Based Biodegradable Neurovascular Stent Prototype: A Preliminary In Vitro and In Vivo Study.

Nikoubashman O, Heringer S, Feher K, Brockmann MA, Sellhaus B, Dreser A, Kurtenbach K, Pjontek R, Jockenhövel S, Weis J, Kießling F, Gries T, Wiesmann M.

Macromol Biosci. 2018 Jul;18(7):e1700292. doi: 10.1002/mabi.201700292. Epub 2018 May 31.

PMID:
29855168
32.

Histidine-rich glycoprotein-induced vascular normalization improves EPR-mediated drug targeting to and into tumors.

Theek B, Baues M, Gremse F, Pola R, Pechar M, Negwer I, Koynov K, Weber B, Barz M, Jahnen-Dechent W, Storm G, Kiessling F, Lammers T.

J Control Release. 2018 Jul 28;282:25-34. doi: 10.1016/j.jconrel.2018.05.002. Epub 2018 May 4.

33.

Semi-Automated Segmentation of the Tumor Vasculature in Contrast-Enhanced Ultrasound Data.

Theek B, Opacic T, Lammers T, Kiessling F.

Ultrasound Med Biol. 2018 Aug;44(8):1910-1917. doi: 10.1016/j.ultrasmedbio.2018.03.015. Epub 2018 May 2.

PMID:
29730066
34.

Motion model ultrasound localization microscopy for preclinical and clinical multiparametric tumor characterization.

Opacic T, Dencks S, Theek B, Piepenbrock M, Ackermann D, Rix A, Lammers T, Stickeler E, Delorme S, Schmitz G, Kiessling F.

Nat Commun. 2018 Apr 18;9(1):1527. doi: 10.1038/s41467-018-03973-8.

35.

Glucocorticoid-loaded liposomes induce a pro-resolution phenotype in human primary macrophages to support chronic wound healing.

Gauthier A, Fisch A, Seuwen K, Baumgarten B, Ruffner H, Aebi A, Rausch M, Kiessling F, Bartneck M, Weiskirchen R, Tacke F, Storm G, Lammers T, Ludwig MG.

Biomaterials. 2018 Sep;178:481-495. doi: 10.1016/j.biomaterials.2018.04.006. Epub 2018 Apr 5.

PMID:
29650255
36.

Advanced Ultrasound Technologies for Diagnosis and Therapy.

Rix A, Lederle W, Theek B, Lammers T, Moonen C, Schmitz G, Kiessling F.

J Nucl Med. 2018 May;59(5):740-746. doi: 10.2967/jnumed.117.200030. Epub 2018 Mar 1.

37.

The changing face of cancer diagnosis: From computational image analysis to systems biology.

Kiessling F.

Eur Radiol. 2018 Aug;28(8):3160-3164. doi: 10.1007/s00330-018-5347-9. Epub 2018 Feb 27.

PMID:
29488085
38.

Molecular Ultrasound Imaging of Junctional Adhesion Molecule A Depicts Acute Alterations in Blood Flow and Early Endothelial Dysregulation.

Curaj A, Wu Z, Rix A, Gresch O, Sternkopf M, Alampour-Rajabi S, Lammers T, van Zandvoort M, Weber C, Koenen RR, Liehn EA, Kiessling F.

Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):40-48. doi: 10.1161/ATVBAHA.117.309503. Epub 2017 Nov 30.

PMID:
29191926
39.

Fibrosis imaging: Current concepts and future directions.

Baues M, Dasgupta A, Ehling J, Prakash J, Boor P, Tacke F, Kiessling F, Lammers T.

Adv Drug Deliv Rev. 2017 Nov 1;121:9-26. doi: 10.1016/j.addr.2017.10.013. Epub 2017 Nov 20. Review.

40.

Automated Generation of Reliable Blood Velocity Parameter Maps from Contrast-Enhanced Ultrasound Data.

Theek B, Opacic T, Möckel D, Schmitz G, Lammers T, Kiessling F.

Contrast Media Mol Imaging. 2017 May 30;2017:2098324. doi: 10.1155/2017/2098324. eCollection 2017.

41.

Quinone-fused porphyrins as contrast agents for photoacoustic imaging.

Banala S, Fokong S, Brand C, Andreou C, Kräutler B, Rueping M, Kiessling F.

Chem Sci. 2017 Sep 1;8(9):6176-6181. doi: 10.1039/c7sc01369h. Epub 2017 Jun 27.

42.

Nilotinib Enhances Tumor Angiogenesis and Counteracts VEGFR2 Blockade in an Orthotopic Breast Cancer Xenograft Model with Desmoplastic Response.

Zafarnia S, Bzyl-Ibach J, Spivak I, Li Y, Koletnik S, Doleschel D, Rix A, Pochon S, Tardy I, Koyadan S, van Zandvoort M, Palmowski M, Kiessling F, Lederle W.

Neoplasia. 2017 Nov;19(11):896-907. doi: 10.1016/j.neo.2017.08.009. Epub 2017 Sep 20.

43.

Bio-degradable highly fluorescent conjugated polymer nanoparticles for bio-medical imaging applications.

Repenko T, Rix A, Ludwanowski S, Go D, Kiessling F, Lederle W, Kuehne AJC.

Nat Commun. 2017 Sep 7;8(1):470. doi: 10.1038/s41467-017-00545-0.

44.

Comparison of the Accuracy of FMT/CT and PET/MRI for the Assessment of Antibody Biodistribution in Squamous Cell Carcinoma Xenografts.

Hage C, Gremse F, Griessinger CM, Maurer A, Hoffmann SHL, Osl F, Pichler BJ, Kiessling F, Scheuer W, Pöschinger T.

J Nucl Med. 2018 Jan;59(1):44-50. doi: 10.2967/jnumed.117.197178. Epub 2017 Aug 28.

45.

Balancing Passive and Active Targeting to Different Tumor Compartments Using Riboflavin-Functionalized Polymeric Nanocarriers.

Tsvetkova Y, Beztsinna N, Baues M, Klein D, Rix A, Golombek SK, Al Rawashdeh W, Gremse F, Barz M, Koynov K, Banala S, Lederle W, Lammers T, Kiessling F.

Nano Lett. 2017 Aug 9;17(8):4665-4674. doi: 10.1021/acs.nanolett.7b01171. Epub 2017 Jul 27.

PMID:
28715227
46.

Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors.

Ojha T, Pathak V, Shi Y, Hennink WE, Moonen CTW, Storm G, Kiessling F, Lammers T.

Adv Drug Deliv Rev. 2017 Sep 15;119:44-60. doi: 10.1016/j.addr.2017.07.007. Epub 2017 Jul 8. Review.

47.

Photoacoustic imaging of tumor targeting with riboflavin-functionalized theranostic nanocarriers.

Beztsinna N, Tsvetkova Y, Jose J, Rhourri-Frih B, Al Rawashdeh W, Lammers T, Kiessling F, Bestel I.

Int J Nanomedicine. 2017 May 18;12:3813-3825. doi: 10.2147/IJN.S125192. eCollection 2017.

48.

Recent advances in ultrasound-based diagnosis and therapy with micro- and nanometer-sized formulations.

Güvener N, Appold L, de Lorenzi F, Golombek SK, Rizzo LY, Lammers T, Kiessling F.

Methods. 2017 Nov 1;130:4-13. doi: 10.1016/j.ymeth.2017.05.018. Epub 2017 May 24. Review.

PMID:
28552267
49.

Noninvasive Assessment of Elimination and Retention using CT-FMT and Kinetic Whole-body Modeling.

Al Rawashdeh W, Zuo S, Melle A, Appold L, Koletnik S, Tsvetkova Y, Beztsinna N, Pich A, Lammers T, Kiessling F, Gremse F.

Theranostics. 2017 Apr 5;7(6):1499-1510. doi: 10.7150/thno.17263. eCollection 2017.

50.

Singlet oxygen-responsive micelles for enhanced photodynamic therapy.

Li X, Gao M, Xin K, Zhang L, Ding D, Kong D, Wang Z, Shi Y, Kiessling F, Lammers T, Cheng J, Zhao Y.

J Control Release. 2017 Aug 28;260:12-21. doi: 10.1016/j.jconrel.2017.05.025. Epub 2017 May 17.

PMID:
28527734

Supplemental Content

Loading ...
Support Center